Related Experiment Video
Updated: May 21, 2026

09:12
A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
Automated detection of toxigenic Clostridium difficile in clinical samples: isothermal tcdB amplification coupled to
Brian Hicke1, Chris Pasko, Benjamin Groves
1Great Basin Scientific, Salt Lake City, Utah, USA. bhicke@gbscience.com
Journal of Clinical Microbiology
|June 8, 2012
Summary
A new diagnostic test accurately detects toxigenic Clostridium difficile (C. difficile) in under an hour. This rapid assay combines cost-effectiveness with high sensitivity and specificity for improved C. difficile detection.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Infectious Diseases
Background:
- Clostridium difficile is an increasingly identified pathogen in both hospital and community settings.
- The organism possesses a variable pathogenicity locus (PaLoc) encoding toxins A and B.
- Existing diagnostic methods have limitations in cost, sensitivity, or specificity.
Purpose of the Study:
- To develop a rapid, sensitive, and specific diagnostic test for toxigenic C. difficile.
- To combine the cost-effectiveness of immunoassays with the accuracy of DNA amplification.
- To target a genetically stable region within the C. difficile PaLoc.
Main Methods:
- A hot-start isothermal DNA amplification method was developed targeting the tcdB gene sequence.
- Detection was achieved using a multiplexed chip-based hybridization capture readout.
- The assay was automated on an electromechanical instrument for fecal sample analysis.
Main Results:
- The manual assay detected toxigenic C. difficile with high sensitivity and specificity within 1 hour.
- Automated assay demonstrated analytical sensitivity of 10 CFU/sample for C. difficile.
- Testing of 130 patient samples showed 97% sensitivity and 100% specificity.
- The assay successfully discriminated against other enteric bacteria.
Conclusions:
- The developed assay offers a rapid and accurate method for detecting toxigenic C. difficile.
- Automation enhances analytical sensitivity and specificity for clinical sample analysis.
- Further large-scale clinical studies are planned to validate clinical performance.

